QNRX

Quoin Pharmaceuticals, Ltd. - American Depositary Shares (QNRX)

About Quoin Pharmaceuticals, Ltd. - American Depositary Shares (QNRX)

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Details

Daily high

$8.79

Daily low

$8.53

Price at open

$8.72

52 Week High

$54.95

52 Week Low

$5.01

Market cap

5.3M

Dividend yield

0.00%

Volume

3,817

Avg. volume

6,965

P/E ratio

-.03

Quoin Pharmaceuticals, Ltd. - American Depositary Shares News